PHASIFY™ sample preparation can be
applied to any sample type, including
blood, saliva, urine, and water.
CANCER SCREENING AND
At present, liquid biopsy is widely applied in late-stage cancer therapy selection and non-invasive prenatal tests. By enhancing sample quality, PHASIFY™ increases the sensitivity of these tests while reducing costs.
Research efforts aimed at implementing liquid biopsy for early-stage cancer screening must overcome the challenge of detecting low-concentration tumor DNA fragments.
By concentrating and purifying DNA from blood samples, PHASIFY™ can improve the identiﬁcation of low frequency cancer mutations.
In so doing, our technology may help to realize the promise of liquid biopsy for early-stage cancer screening.
POINT-OF-CARE TESTS TO
SUPPORT THE SCREENING,
DIAGNOSIS AND MONITORING
Phase Scientific has developed tests that are capable of detecting infection at various stages, from early exposure to after you’ve been infected. By knowing who is exposed, the more we can help contain the spread of COVID-19.